Zobrazeno 1 - 10
of 361
pro vyhledávání: '"Guido Martignoni"'
Autor:
Enrico Munari, Giulia Querzoli, Matteo Brunelli, Marcella Marconi, Marco Sommaggio, Marco A. Cocchi, Guido Martignoni, George J. Netto, Anna Caliò, Linda Quatrini, Francesca R. Mariotti, Claudio Luchini, Ilaria Girolami, Albino Eccher, Diego Segala, Francesco Ciompi, Giuseppe Zamboni, Lorenzo Moretta, Giuseppe Bogina
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Different programmed cell death-ligand 1 (PD-L1) assays and scoring algorithms are being used in the evaluation of PD-L1 expression for the selection of patients for immunotherapy in specific settings of advanced urothelial carcinoma (UC). In this pa
Externí odkaz:
https://doaj.org/article/00d6198449924517bf4712476032448f
Autor:
Crescenzo D’Alterio, Alessandro Giardino, Giosuè Scognamiglio, Giovanni Butturini, Luigi Portella, Giuseppe Guardascione, Isabella Frigerio, Marco Montella, Stefano Gobbo, Guido Martignoni, Vincenzo Napolitano, Ferdinando De Vita, Fabiana Tatangelo, Renato Franco, Stefania Scala
Publikováno v:
Cells, Vol 11, Iss 21, p 3340 (2022)
Pancreatic ductal adenocarcinoma (PDAC) is currently the most deadly cancer. Although characterized by 5–20% of neoplastic cells in the highly fibrotic stroma, immunotherapy is not a valid option in PDAC treatment. As CXCR4-CXCL12 regulates tumor i
Externí odkaz:
https://doaj.org/article/fe998c8283b640b7a26ea9b6fe3ab49c
Autor:
Marco Chilosi, Claudio Doglioni, Claudia Ravaglia, Guido Martignoni, Gian Luca Salvagno, Giovanni Pizzolo, Vincenzo Bronte, Venerino Poletti
Publikováno v:
Biomedicines, Vol 10, Iss 6, p 1332 (2022)
Despite intense investigation, the pathogenesis of COVID-19 and the newly defined long COVID-19 syndrome are not fully understood. Increasing evidence has been provided of metabolic alterations characterizing this group of disorders, with particular
Externí odkaz:
https://doaj.org/article/974d85f29d1e4aba88ee31c60150fb35
Autor:
Enrico Munari, Marcella Marconi, Giulia Querzoli, Gianluigi Lunardi, Pietro Bertoglio, Francesco Ciompi, Alice Tosadori, Albino Eccher, Nicola Tumino, Linda Quatrini, Paola Vacca, Giulio Rossi, Alberto Cavazza, Guido Martignoni, Matteo Brunelli, George J. Netto, Lorenzo Moretta, Giuseppe Zamboni, Giuseppe Bogina
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The immune infiltrate within tumors has proved to be very powerful in the prognostic stratification of patients and much attention is also being paid towards its predictive value. In this work we therefore aimed at clarifying the significance and imp
Externí odkaz:
https://doaj.org/article/38fce130e5484fd6927b40f8831e269c
Autor:
Francesca Giunchi, Tania Franceschini, Elisa Gruppioni, Annalisa Altimari, Elisa Capizzi, Francesco Massari, Riccardo Schiavina, Matteo Brunelli, Guido Martignoni, Michelangelo Fiorentino
Publikováno v:
Diagnostics, Vol 10, Iss 2, p 123 (2020)
Background: Clear cell tubulo-papillary renal cell carcinoma (cctpRCC) is characterized by clear cell morphology, but differs from conventional clear cell carcinoma (ccRCC) for its indolent clinical behavior and genetic background. The differential d
Externí odkaz:
https://doaj.org/article/d16d5aab589e44ac8c5bbbd4e62b8398
Autor:
Antonio Benito Porcaro, Giovanni Novella, Matteo Balzarro, Guido Martignoni, Matteo Brunelli, Giovanni Cacciamani, Maria A. Cerruto, Walter Artibani
Publikováno v:
Asian Journal of Urology, Vol 2, Iss 4, Pp 224-232 (2015)
Objective: In prostate specimens, chronic inflammatory infiltrate (CII) type IV has been detected, but its association with prostate cancer (PCa) is controversial. The aim of the present study is to investigate on associations of CII with PCa detecti
Externí odkaz:
https://doaj.org/article/c62fd339395f4b9d8bbe3b11d3cb2041
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder.
Autor:
Francesco Massari, Emilio Bria, Chiara Ciccarese, Enrico Munari, Alessandra Modena, Valentina Zambonin, Isabella Sperduti, Walter Artibani, Liang Cheng, Guido Martignoni, Giampaolo Tortora, Matteo Brunelli
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0127908 (2015)
To date, putative prognostic biomarkers have shown limited utility from the clinical perspective for bladder urothelial carcinoma. Herein, the expression of beta-tubulin-3 and c-Myc was evaluated to determine their prognostic potential.In formalin fi
Externí odkaz:
https://doaj.org/article/b26746538fef4929a4e7408a90de0d2f
Autor:
Cinzia Scambi, Sara Ugolini, T Sakari Jokiranta, Lucia De Franceschi, Oscar Bortolami, Valentina La Verde, Patrizia Guarini, Paola Caramaschi, Viviana Ravagnani, Guido Martignoni, Chiara Colato, Serena Pedron, Fabio Benedetti, Marco Sorio, Fabio Poli, Domenico Biasi
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0114856 (2015)
OBJECTIVE:The role of complement system in the pathogenesis of systemic sclerosis (SSc) has been debated during the last decade but an evident implication in this disease has never been found. We carried out an explorative study on SSc patients to ev
Externí odkaz:
https://doaj.org/article/4d90300ee2374266bffbe2f1ce1f2bc0
Autor:
Federica Pedica, Andrea Ruzzenente, Fabio Bagante, Paola Capelli, Ivana Cataldo, Serena Pedron, Calogero Iacono, Marco Chilosi, Aldo Scarpa, Matteo Brunelli, Anna Tomezzoli, Guido Martignoni, Alfredo Guglielmi
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e68203 (2013)
Hepatocellular carcinoma is one leading cause of cancer-related death and surgical resection is still one of the major curative therapies. Recently, there has been a major effort to find mechanisms involved in carcinogenesis and early relapse. c-myc
Externí odkaz:
https://doaj.org/article/4249c3bb0e05449f9cb68f0d8ad52820
Autor:
Matteo Brunelli, Emilio Bria, Alessia Nottegar, Sara Cingarlini, Francesca Simionato, Anna Caliò, Albino Eccher, Claudia Parolini, Antonio Iannucci, Eliana Gilioli, Serena Pedron, Francesco Massari, Giampaolo Tortora, Ioana Borze, Sakari Knuutila, Stefano Gobbo, Antonio Santo, Luca Tondulli, Francesco Calabrò, Guido Martignoni, Marco Chilosi
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e49689 (2012)
Squamous lung carcinoma lacks specific "ad hoc" therapies. Amplification of chromosome 3q is the most common genomic aberration and this region harbours genes having role as novel targets for therapeutics. There is no standard definition on how to sc
Externí odkaz:
https://doaj.org/article/c836151bf57a4429b7a03c2bb3ae5354